Dog /

Breed profile · FDA CVM July 2026 extract

Griffon - French Wire-haired Pointing adverse-event record

Adverse-event filings for Griffon - French Wire-haired Pointing (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

Verify with FDA CVM →
#179 of 510
by report volume (all breeds)
227
FDA CVM reports on file
0.4%
death-coded share of reports
#275 of 275
by death-coded share (≥50 reports)

How the 227 reports break down

By recorded gender -- every report on file for Griffon - French Wire-haired Pointing, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 34 25.5 17 8.5 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Griffon - French Wire-haired Pointing drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Griffon - French Wire-haired Pointing ranks #179 of 510 by total reports (227) and #275 of 275 by death-coded share (0.4%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#179
This breed, reports of 510
#275
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Griffon - French Wire-haired Pointing has 227 reports now versus 225 in that prior snapshot: 2 more (0.9%).

Report change
+2
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Griffon - French Wire-haired Pointing changes

Total Reports

227

Above-median volume

Deaths Reported

1

of 227 reports

Death-coded share of reports

0.4%

Lowest death-coded share

Avg Age at Report

4.4 yr

26.1 kg avg weight

Breed Safety Scorecard

C (56/100)

A weighted composite across 3 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate A+
0.4%

Share of reports coded as a fatality

Euthanasia rate N/A
N/A

Share of reports resulting in euthanasia

Full recovery rate F
24.7%

Share of reports coded "Recovered/Normal"

5-year trend F
+92%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Griffon - French Wire-haired Pointing death-coded reports 0.4%
Cross-breed median

0.4% of 227 griffon - french wire-haired pointing reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Griffon - French Wire-haired Pointing's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

0% 0th percentile Higher share than 0% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Griffon - French Wire-haired Pointing 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 26.1 kg (57.6 lbs)

Top Reported Reactions

Vomiting 39
Lack of efficacy (endoparasite) - hookworm 25
Diarrhoea 21
Digestive tract disorder NOS 20
Lethargy (see also Central nervous system depression in 'Neurological') 19
Lack of efficacy (endoparasite) - heartworm 13
INEFFECTIVE, ASCARIDS NOS 11
Lack of efficacy (ectoparasite) - tick NOS 11

Most Referenced Drugs

Ivermectin + Pyrantel As Pamoate Salt 41
Afoxolaner 23
Pyrantel Pamoate;Sarolaner 21
Milbemycin Oxime + Spinosad 20
Fluralaner Chew Tablets 16
Milbemycin Oxime + Praziquantel 13
Bedinvetmab 11
Fluralaner 13.64% 12-Week Chew 10

Outcome Breakdown

Outcome Unknown
81 (37.5%)
Ongoing
72 (33.3%)
Recovered/Normal
56 (25.9%)
Recovered with Sequela
6 (2.8%)
Died
1 (0.5%)

Gender Distribution

Male 115 (50.7%)
Female 110 (48.5%)
Mixed 1 (0.4%)
Unknown 1 (0.4%)

Reports by Year

Year Reports Trend
2010 4
2011 9
2012 8
2013 9
2014 7
2015 13
2016 11
2017 23
2018 15
2019 13
2020 9
2021 12
2022 13
2023 34
2024 22
2025 23
2026 2

Griffon - French Wire-haired Pointing: low death-coded share in the FDA CVM extract

Signature read: Griffon - French Wire-haired Pointing's 0.4% death-coded share is in the lower third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Griffon - French Wire-haired Pointing sits at #179 of 510 by report volume among all breeds and #142 of 298 among dog breeds, with 227 reports and 1 (0.4%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #275 of 275. Mean age at report: 4.4 years, average weight 26.1 kg (57.6 lbs).

Top reported signs: Vomiting (39), Lack of efficacy (endoparasite) - hookworm (25), Diarrhoea (21). Most-referenced drug: Ivermectin + Pyrantel As Pamoate Salt (41 reports), followed by Afoxolaner (23) and Pyrantel Pamoate;Sarolaner (21).

Outcome coding on 216 status-recorded reports is dominated by Outcome Unknown (37.5%). Annual submissions ranged 2-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Terrier - American Staffordshire
227 reports · 2.2% death-coded
Setter - Gordon
231 reports · 5.2% death-coded
Spaniel - Tibetan
222 reports · 5.0% death-coded
Treeing Feist
221 reports · 1.8% death-coded
Terrier - Norwich
234 reports · 3.0% death-coded
Coonhound - Redbone
214 reports · 3.7% death-coded

Nationwide breeds with similar profiles

Two openFDA-derived peer sets for Griffon - French Wire-haired Pointing, both outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (0.4% death-coded here).

Turkish Angora 1.3% · Cat Hanovarian 2.2% · Horse Warmblood - Dutch 2.7% · Horse Oldenburg 2.8% · Horse

Similar average weight

Nearest other-species breeds by reported average weight (26.1 kg here).

Mixed (Sheep) 24.9 kg · Sheep Crossbred Caprine/goat 21.7 kg · Goat Pygmy 20.3 kg · Goat Fish (other) 32.4 kg · Fish

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Griffon - French Wire-haired Pointing? ▼
There are 227 adverse event reports involving Griffon - French Wire-haired Pointing in the FDA database, of which 1 were death-coded (0.4% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Griffon - French Wire-haired Pointing ranks #179 of 510 by report volume among all breeds PlainBreed indexes (#142 of 298 among dog breeds).
Where does Griffon - French Wire-haired Pointing sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Griffon - French Wire-haired Pointing is #179 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #142 of 298. Among breeds with at least 50 reports, its death-coded share ranks #275 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Griffon - French Wire-haired Pointing? ▼
The most commonly reported adverse reactions for Griffon - French Wire-haired Pointing are Vomiting (39 reports), Lack of efficacy (endoparasite) - hookworm (25 reports), Diarrhoea (21 reports), Digestive tract disorder NOS (20 reports), Lethargy (see also Central nervous system depression in 'Neurological') (19 reports).
What drugs are most frequently associated with Griffon - French Wire-haired Pointing adverse events? ▼
The drugs most frequently referenced in Griffon - French Wire-haired Pointing adverse event reports are Ivermectin + Pyrantel As Pamoate Salt (41 reports), Afoxolaner (23 reports), Pyrantel Pamoate;Sarolaner (21 reports), Milbemycin Oxime + Spinosad (20 reports), Fluralaner Chew Tablets (16 reports).
What is the average age of Griffon - French Wire-haired Pointing in adverse event reports? ▼
The average age of Griffon - French Wire-haired Pointing at the time of adverse event reports is 4.4 years, with an average weight of 26.1 kg (57.6 lbs).

Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Griffon - French Wire-haired Pointing (Dog), extract as of July 2026 extract. 227 reports · 1 death-coded (0.4% of reports, not a mortality rate) · #179 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →